Baseline cardiovascular risk factors common in patients with type 2 diabetes and obesity include: Prolonged immobility or sedentary lifestyle History of previous blood clots or thromboembolism Active cancer or recent cancer treatment Recent surgery, particularly orthopedic or abdominal procedures Smoking or tobacco use Hypertension and dyslipidemia Family history of clotting disorders Use of estrogen-containing medications (oral contraceptives, hormone replacement therapy) Pregnancy or postpartum period Chronic inflammatory conditions Patients with obesity face additional thrombotic risk due to chronic low-grade inflammation, endothelial dysfunction, and increased prothrombotic factors
Wash hands after application to avoid staining fabric
Research suggests that tesamorelin effectively reduces triglyceride, total cholesterol and LDL-C levels
Nausea, mild diarrhea, reduced appetite, and fatigue are most frequent during weeks 13, typically resolving as the body adjusts
Immunoassays for the measurement of IGF-II, IGFBP-2 and -3, and ICTP as indirect biomarkers of recombinant human growth hormone misuse in sport
Some people discover they are drinking far less water than they assumed
